scholarly journals The Importance of Sensitivity Analysis in Assessing Clinical and Economic Impact of National Immunization Programs: An Example of Slovenia

2014 ◽  
Vol 17 (7) ◽  
pp. A676
Author(s):  
R. Hren ◽  
E. Delgleize
2021 ◽  
Author(s):  
Siobhan Botwright ◽  
Birgitte K. Giersing ◽  
Martin I. Meltzer ◽  
Anna-Lea Kahn ◽  
Mark Jit ◽  
...  

Author(s):  
A. Çigdem Simsek ◽  
Elif Arabulan ◽  
Nilufer Tavukçu ◽  
Sertaç Çankaya ◽  
Belgin Gulhan ◽  
...  

Vaccines ◽  
2021 ◽  
Vol 9 (3) ◽  
pp. 256
Author(s):  
Pedro Plans-Rubió

In 2012, the World Health Organization (WHO) established the Global Vaccine Action Plan with the objective to promote essential vaccinations in all countries and achieve at least 90% vaccination coverage for all routine vaccines by 2020. The study assessed the mean percentages of vaccination coverage in 2019 for 13 routine vaccines, vaccination coverage variation from 2015 to 2019, and herd immunity levels against measles and pertussis in 2019 in countries and regions of WHO. In 2019, the mean percentages of vaccination coverage were lower than 90% for 10 (78.9%) routine vaccines. The mean percentages of vaccination coverage also decreased from 2015 to 2019 for six (46.2%) routine vaccines. The prevalence of individuals with vaccine-induced measles immunity in the target measles vaccination population was 88.1%, and the prevalence of individuals with vaccine-induced pertussis immunity in the target pertussis vaccination population was 81.1%. Herd immunity against measles viruses with Ro = 18 was established in 63 (32.5%) countries but not established in any region. Herd immunity against pertussis agents was not established in any country and in any region of WHO. National immunization programs must be improved to achieve ≥90% vaccination coverage in all countries and regions. Likewise, it is necessary to achieve ≥95% vaccination coverage with two doses of measles vaccines and three doses of pertussis vaccines in all countries and regions.


2010 ◽  
Vol 121-122 ◽  
pp. 756-759
Author(s):  
Tao Ye

The development of photovoltaic industry can produce great socio-economic implications in terms of induced production and job creation. The world photovoltaic market has been growing and will be strongly influenced by photovoltaic costs and available technologies.. The overall cost to implement a facility for module production having a capacity per year that may be regarded as the minimum profitable size for module production in China is considered. An input–output analysis is used for assessing the relative economic impact on production and employment. A sensitivity analysis shows that the results are reasonably robust.


2014 ◽  
Vol 3 ◽  
pp. 146-155 ◽  
Author(s):  
Syed Aljunid ◽  
Namaitijiang Maimaiti ◽  
Zafar Ahmed ◽  
Amrizal Muhammad Nur ◽  
Zaleha Md Isa ◽  
...  

Author(s):  
Henry Biose ◽  
Adewale Dosunmu ◽  
Chijioke Nwaozuzu

The paper presents the economic benefits of the long term development of gas pipeline infrastructure in Nigeria. The study reviewed related literature and modeled a sensitivity analysis of the tax rate with tax holiday, without tax holiday and economic impact analysis. The sensitivity analysis of tax rate with tax holiday and without tax holiday was also evaluated and it indicated that the 20% corporate income is more viable for gas pipeline projects in Nigeria. The economic impact analysis evaluated the direct, indirect and induced impact of the gas pipeline project on GDP, employment and tax revenue in Nigeria with respect to short term (5 years), medium term (15 years) and long term (40 years): The impacts analysis indicates a total GDP of 60 billion USD, 55,626 jobs created and 1.6 billion USD tax revenue generated as a result of the gas pipeline project.


2018 ◽  
pp. 102-109 ◽  
Author(s):  
G. L. Ignatova ◽  
V. N. Antonov ◽  
M. P. Kostinov ◽  
A. D. Protasov

The studies of the serotype composition of pneumococci in various countries indicate that over 80% of the most severe invasive diseases are caused by 20 serotypes, and 13 serotypes cause 70–75% of diseases globally [3]. The vaccination of the population is the main way to reduce the incidence of both invasive and non-invasive pneumococcal infections. With evidence of the safety and efficacy of pneumococcal conjugate vaccines, WHO and UNCF consider it necessary to include these vaccines for children in the national immunization programs around the world.


2013 ◽  
Vol 02 (04) ◽  
pp. 187-192 ◽  
Author(s):  
Partha Basu ◽  
Dipanwita Banerjee ◽  
Priyanka Singh ◽  
Chandrani Bhattacharya ◽  
Jaydip Biswas

AbstractThe Human Papillomavirus (HPV) vaccines have been widely introduced in the national immunization programs in most of the medium and high income countries following endorsement from national and international advisory bodies. HPV vaccine is unique and its introduction is challenging in many ways – it is the first vaccine developed to prevent any cancer, the vaccine is gender specific, it targets adolescent females who are difficult to reach by any health intervention programs. It is not unusual for such a vaccine to face scepticism and reservations not only from lay public but also from professionals in spite of the clinical trial results convincingly and consistently proving their efficacy and safety. Over the last few years millions of doses of the HPV vaccine have been administered round the world and the efficacy and safety data have started coming from the real life programs. A comprehensive cervical cancer control program involving HPV vaccination of the adolescent girls and screening of the adult women has been proved to be the most cost‑effective approach to reduce the burden of cervical cancer. The present article discusses the justification of HPV vaccination in the backdrop of natural history of cervical cancer, the mechanism of action of the vaccines, efficacy and safety data from phase III randomized controlled trials as well as from the national immunization programs of various countries.


Sign in / Sign up

Export Citation Format

Share Document